Clinical Trials
3
Active:1
Completed:0
Trial Phases
1 Phases
Phase 1:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1
3 (100.0%)A Multicenter, Study of the Safety and Pharmacokinetics of Intravenously Infused Berubicin in Pediatric Patients With Progressive, Refractory, or Recurrent High Grade Gliomas
- First Posted Date
- 2021-10-19
- Last Posted Date
- 2024-06-06
- Lead Sponsor
- WPD Pharmaceuticals Sp. z o.o.
- Registration Number
- NCT05082493
Berubicin in Adult Patients With Recurrent Glioblastoma Multiforme (WHO Grade IV)
Phase 1
Terminated
- Conditions
- Recurrent Glioblastoma Multiforme
- Interventions
- First Posted Date
- 2021-06-07
- Last Posted Date
- 2024-06-06
- Lead Sponsor
- WPD Pharmaceuticals Sp. z o.o.
- Target Recruit Count
- 5
- Registration Number
- NCT04915404
- Locations
- 🇵🇱
Uniwersyteckie Centrum Kliniczne Klinika Onkoligii i Radioterapii, Gdańsk, Poland
🇵🇱Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie,Państwowy Instytut Badawczy w Warszawie,Klinika Nowotworów Głowy i Szyi, Warszawa, Poland
News
No news found